Analysis of different HER‐2 mutations in breast cancer progression and drug resistance

Studies over the last two decades have identified that amplified human epidermal growth factor receptor (HER‐2; c‐erbB‐2, neu) and its overexpression have been frequently implicated in the carcinogenesis and prognosis in a variety of solid tumours, especially breast cancer. Lots of painstaking effor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zijia, Shi, Yaqin, Shen, Yan, Cao, Lulu, Zhang, Wenwen, Guan, Xiaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687700/
https://www.ncbi.nlm.nih.gov/pubmed/26305917
http://dx.doi.org/10.1111/jcmm.12662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687700/
https://www.ncbi.nlm.nih.gov/pubmed/26305917
http://dx.doi.org/10.1111/jcmm.12662

Ejemplares similares